CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Inhibition of Phosphodiesterase 5– a Novel Therapeutic Strategy for Portal Hypertension
DOI 10.1055/s-2005-919999
Bibliografische Angaben
Nachweis in CareLit
Autor:innenP Deibert, O Opitz, YO Schumacher, M Rössle, HE Blum, W Kreisel
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe04/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Nitric oxide – cyclic GMP mediated vasodilatation is a key factor in the regulation of blood flow in the splanchnic system and the liver and may be a target for medical treatment of portal hypertension. We investigated whether inhibition of phosphodiesterase–5 (PDE–5) influences portal blood flow and portal pressure. Methods: To 18 healthy subjects and 18 patients with Child A liver cirrhosis 10mg of V…
Zitieren
Zitierempfehlung
P Deibert, O Opitz, YO Schumacher, M Rössle, HE Blum, W Kreisel (2006) Inhibition of Phosphodiesterase 5– a Novel Therapeutic Strategy for Portal Hypertension. Zeitschrift für Gastroenterologie (04). https://doi.org/10.1055/s-2005-919999
Mit CareLit weiterarbeiten